These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8108977)

  • 21. Post-transplantation renal impairment and intravenous immunoglobulin.
    Harden PN; Robertson S; Isles CG; Rodger RS
    Nephrol Dial Transplant; 1996 Sep; 11(9):1896. PubMed ID: 8918656
    [No Abstract]   [Full Text] [Related]  

  • 22. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of kidney function in pediatric transplantation.
    Lubrano R; Trapasso E; Brenna S; Castello MA; Pretagostini R; Alfani D; Poli L; Berloco P; Cortesini R
    Transplant Proc; 1994 Feb; 26(1):52-3. PubMed ID: 8109019
    [No Abstract]   [Full Text] [Related]  

  • 24. Endothelins in hypertension and kidney diseases.
    Ivić MA; Stefanović V
    Pathol Biol (Paris); 1998 Nov; 46(9):723-30. PubMed ID: 9885830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience.
    Andreu J; Campistol JM; Oppenheimer F; Torregrosa V; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1994 Feb; 26(1):337-40. PubMed ID: 8109006
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood serum osteocalcin and beta-crosslaps concentrations in patients after renal transplantation].
    Zbróg Z; Tomaszek M; Szuflet A; Pierzchalska-Mudyna T; Rybińska A; Skrzypek A; Matych J
    Przegl Lek; 2007; 64(6):431-4. PubMed ID: 18159853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum testosterone levels after renal transplantation.
    Ishikawa A; Ushiyama T; Suzuki K; Fujita K
    Transplant Proc; 1996 Jun; 28(3):1952-3. PubMed ID: 8658958
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical algorithms for cyclosporine management based on pathophysiologic constructs of nephrotoxicity.
    Bennett WM
    Transplant Proc; 1994 Oct; 26(5):2583-4. PubMed ID: 7940801
    [No Abstract]   [Full Text] [Related]  

  • 29. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation.
    Vamvakas S; Bahner U; Becker P; Steinle A; Götz R; Heidland A
    Transplant Proc; 1996 Dec; 28(6):3468-73. PubMed ID: 8962350
    [No Abstract]   [Full Text] [Related]  

  • 30. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 32. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
    Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
    Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplantation of pediatric low-weight kidneys into adults from a non-heart-beating donor.
    Taguchi Y; Koyama I; Honda H; Hayashi T; Nagashima N; Shinozuka N; Omoto R
    Transplant Proc; 1996 Jun; 28(3):1535-6. PubMed ID: 8658775
    [No Abstract]   [Full Text] [Related]  

  • 35. Blockade of cyclosporine-induced vasoconstriction by the calcium channel blocker diltiazem in dogs.
    Carrier M; Tronc F; Stewart D; Nattel S; Pelletier LC
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):487-90. PubMed ID: 8361192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
    Barone G; Bunke CM; Choc MG; Hricik DE; Jin JH; Klein JB; Marsh CL; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
    Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
    [No Abstract]   [Full Text] [Related]  

  • 38. [Renal lymphoma in a transplanted patient treated with cyclosporine].
    Drahy G; Dion E; Faucher C; Bellin MF
    J Urol (Paris); 1993; 99(1):35-7. PubMed ID: 8515091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful kidney transplantation in small children.
    Aichberger C; Königsrainer A; Ofner D; Fischer H; Meister B; Margreiter R
    Transplant Proc; 1994 Feb; 26(1):49. PubMed ID: 8109016
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of renal function in transplantation.
    Poggio ED; Batty DS; Flechner SM
    Transplantation; 2007 Jul; 84(2):131-6. PubMed ID: 17667802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.